您使用提示模式 关闭

BMED - BlackRock Future Health ETF (USD) (US09290C4006)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
US09290C4006
BMED ISIN
交易所交易基金 (ETF)
基金类型
BlackRock
提供商
28,48 USD
每股资产净值 | 2026-06-15
2020-09-29
成立日期
2 每年的次数
股息的支付
CEOJLS
CFI
BMED
代码
Formed
Status
Equity
投资项目
Healthcare
部门
Global
地区分布
MSCI All Country World Index
基准
0.85 %
总成本比率
Physical
复制方法
9,81 百万 USD
基金资产总量 | 2026-05-15
UCITS

收益率 在 2026-06-15, NYSE Arca

  • YTD
    -10,06 %
  • 1M
    -7,49 %
  • 3M
    -11,48 %
  • 6M
    -6,8 %
  • 1Y
    14,08 %
  • 3Y
    12,41 %
  • 5Y
    -3,07 %
  • 10Y
    -
按交换价格计算,包括收入支付

最新数据在
添加比较项目

报价 (BMED)

探索最全面的数据库

1 000 000

债券

80 234

股票

167 970

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件

价格动态的变化

Fund profile

The BlackRock Future Health ETF is an actively managed ETF that seeks long-term capital appreciation, and invests in a portfolio comprised primarily of innovative and emerging companies in the healthcare sector

BMED profile

The BlackRock Future Health ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Global. The BlackRock fund’s base currency is USD and the share class was registered 29.09.2020 with unique ISIN - US09290C4006. Main exchange is NYSE Arca and ticker symbol is BMED. The total expense ratio is 0.85%. The BlackRock Future Health ETF (USD) pays dividends 2 time(s) per year.

结构 BMED 在 2026-05-14

证券
JOHNSON & JOHNSON 8,02%
BLK CSH FND TREASURY SL AGENCY 5,72%
GILEAD SCIENCES INC 5,52%
EDWARDS LIFESCIENCES CORP 4,68%
MERCK & CO INC 4,12%
BIOGEN INC 3,72%
AMGEN INC 3,53%
WATERS CORP 3,46%
WUXI BIOLOGICS CAYMAN INC 3,18%
VERTEX PHARMACEUTICALS INC 3,12%
ARGENX SE ADR 3,04%
MODERNA INC 2,92%
CHARLES RIVER LABORATORIES INTERNA 2,85%
BRUKER CORP 2,83%
METTLER TOLEDO INC 2,56%
PFIZER INC 2,43%
NOVARTIS AG 2,37%
DANAHER CORP 2,31%
PROTAGONIST THERAPEUTICS INC 2,15%
DEXCOM INC 2,03%
GSK AMERICAN DEPOSITORY SHARES REP 2,01%
THERMO FISHER SCIENTIFIC INC 1,84%
ROCHE PS PAR AG 1,83%
TEVA PHARMACEUTICAL INDUSTRIES ADR 1,74%
BIO TECHNE CORP 1,71%
UCB SA 1,65%
ASTRAZENECA PLC 1,63%
INCYTE CORP 1,61%
INSMED INC 1,54%
NEUROCRINE BIOSCIENCES INC 1,54%
COGENT BIOSCIENCES INC 1,51%
BOSTON SCIENTIFIC CORP 1,31%
BRISTOL MYERS SQUIBB 1,24%
BIOMARIN PHARMACEUTICAL INC 1,22%
REVOLUTION MEDICINES INC 1,09%
UNITEDHEALTH GROUP INC 1,03%
AXSOME THERAPEUTICS INC 1,02%
INTUITIVE SURGICAL INC 0,98%
ALCON AG 0,87%
ARCUS BIOSCIENCES INC 0,64%
DIANTHUS THERAPEUTICS INC 0,56%
CYTOKINETICS INC 0,53%
APOGEE THERAPEUTICS INC 0,49%
BIONTECH SE ADR 0,47%
EIKON THERAPEUTICS INC 0,17%
AVALO THERAPEUTICS INC 0,15%
ERASCA INC 0,13%
SAGIMET BIOSCIENCES INC SERIES A 0,12%
ULTRAGENYX PHARMACEUTICAL INC 0,12%
SUMMIT THERAPEUTICS INC 0,12%
EUR CASH 0,01%
KORRO BIO INC CVR 0%
KRW CASH 0%
VIGIL NEUROSCIENCE INC CVR 0%
HKD CASH 0%
BLUEPRINT MEDICINES CORP 0%
GBP CASH 0%
MIRATI THERAPEUTICS INC 0%
ABIOMED CVRS 0%
USD CASH -1,43%
Other - %

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权